Enbrel Patent Could Delay Generic Competition Until 2028 | Rheumatoid Arthritis Guy
Links shared publicly online about this topic.
- 0total visits
Enbrel Patent Could Delay Generic Competition Until 2028 | Rheumatoid Arthritis Guy
“Amgen said Tuesday that a new patent had been granted that could protect its big-selling drug Enbrel from generic competition for 17 more years, a development…
View full resource at rheumatoidarthritisguy.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug, Enbrel
Most Recently Shared on November 28, 2011 at 4:24 pm By:
Enbrel Patent Could Delay Generic Competition Until 2028 http://t.co/4OmeavTa
Advertisement
